Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease

B Wilson, KM Geetha - Journal of controlled release, 2020 - Elsevier
Alzheimer's disease (AD) is a progressive, irreversible, fatal brain disease which disturbs
cognitive functions. It affects 35 million people worldwide and the number of people suffering …

Update on Therapeutic potential of emerging nanoformulations of phytocompounds in Alzheimer's and Parkinson's disease

N Kanojia, K Thapa, G Kaur, A Sharma, V Puri… - Journal of Drug Delivery …, 2023 - Elsevier
The prevalence of neurodegenerative disorders (NDs) has increased recently, with
Parkinson's disease (PD) and Alzheimer's disease (AD) being the two utmost prevalent …

Nanotechnology based theranostic approaches in Alzheimer's disease management: current status and future perspective

J Ahmad, S Akhter, M Rizwanullah… - Current Alzheimer …, 2017 - ingentaconnect.com
Background: Alzheimer's disease (AD), a cognitive dysfunction/dementia state amongst the
elders is characterized by irreversible neurodegeneration due to varied pathophysiology. Up …

[HTML][HTML] Natural product-based nanomedicine: Recent advances and issues for the treatment of Alzheimer's disease

CK Woon, WK Hui, R Abas, MH Haron… - Current …, 2022 - ncbi.nlm.nih.gov
Alzheimer's disease (AD) affects the elderly and is characterized by progressive
neurodegeneration caused by different pathologies. The most significant challenges in …

Nanotechnology to improve the Alzheimer's disease therapy with natural compounds

MJ Ramalho, S Andrade, JA Loureiro… - Drug delivery and …, 2020 - Springer
Alzheimer's disease (AD) is a form of dementia with high impact worldwide, accounting with
more than 46 million cases. It is estimated that the number of patients will be four times …

[HTML][HTML] Advancements in the Application of Nanomedicine in Alzheimer's Disease: A Therapeutic Perspective

N Puranik, D Yadav, M Song - International Journal of Molecular Sciences, 2023 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disease that affects most
people worldwide. AD is a complex central nervous system disorder. Several drugs have …

[HTML][HTML] Nanomedicine in the management of Alzheimer's disease: State-of-the-art

SN Mir Najib Ullah, O Afzal, ASA Altamimi, H Ather… - Biomedicines, 2023 - mdpi.com
Alzheimer's disease (AD) is a deadly, progressive, and irreversible brain condition that
impairs cognitive abilities. Globally, it affects 32.6 million individuals, and if no viable …

[HTML][HTML] Advances in developing therapeutic strategies for Alzheimer's disease

TT Nguyen, TTD Nguyen, TKO Nguyen, TK Vo - Biomedicine & …, 2021 - Elsevier
Alzheimer's disease (AD) is a progressive deterioration of brain function, initially
characterized by cognitive deficits, with loss of recent memory and language ability …

Nanomaterials in Alzheimer's disease treatment: a comprehensive review

M Faiyaz, MA Ganayee, S Akhtar… - Frontiers in …, 2021 - research.aalto.fi
Alzheimer's, a progressive neurodegenerative disease affects brain and neurons through
enormous reduction in nerve cell regenerative capacity. Dementia and impairment of …

The potential benefits of nanotechnology in treating Alzheimer's disease

TS Ling, S Chandrasegaran, LZ Xuan… - BioMed research …, 2021 - Wiley Online Library
Alzheimer's disease is a neurodegenerative disorder that is caused by the accumulation of
beta‐amyloid plaques in the brain. Currently, there is no definitive cure available to treat …